Biotech · Private company
Delta-Fly Pharma, Inc.
Track this companyFree. Adds Delta-Fly Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- AzacitidinePhase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- CytarabinePhase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- DecitabinePhase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- DFP-10917Phase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- EtoposidePhase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- MitoxantronePhase 3 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- DFP-10917Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- DFP-14927Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Oral DFP-11207Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaPHASE1_PHASE2 · UNKNOWN · started Jun 12, 2024ClinicalTrials.gov NCT06382168 · fetched Nov 12, 2026
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvagePHASE3 · TERMINATED · started Nov 22, 2019ClinicalTrials.gov NCT03926624 · fetched Nov 12, 2026
- Trial of DFP-14927 in Advanced Solid TumorsPHASE1 · RECRUITING · started Sep 30, 2019ClinicalTrials.gov NCT03943004 · fetched Nov 12, 2026
- Phase I Study of Oral DFP-11207 in Solid TumorsPHASE1 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02171221 · fetched Nov 12, 2026
- Phase I/II Study of DFP-10917 in Patients With Acute LeukemiaPHASE1_PHASE2 · COMPLETED · started Oct 10, 2012ClinicalTrials.gov NCT01702155 · fetched Nov 12, 2026